DE60141992D1 - - Google Patents
Info
- Publication number
- DE60141992D1 DE60141992D1 DE60141992T DE60141992T DE60141992D1 DE 60141992 D1 DE60141992 D1 DE 60141992D1 DE 60141992 T DE60141992 T DE 60141992T DE 60141992 T DE60141992 T DE 60141992T DE 60141992 D1 DE60141992 D1 DE 60141992D1
- Authority
- DE
- Germany
- Prior art keywords
- chemotherapeutic drug
- compositions
- peptide
- cleavable
- conjugated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22973300P | 2000-09-05 | 2000-09-05 | |
PCT/IL2001/000839 WO2002020715A2 (en) | 2000-09-05 | 2001-09-05 | Peptide conjugated anti-cancer prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60141992D1 true DE60141992D1 (de) | 2010-06-10 |
Family
ID=22862481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60141992T Expired - Lifetime DE60141992D1 (de) | 2000-09-05 | 2001-09-05 |
Country Status (7)
Country | Link |
---|---|
US (2) | US7135547B2 (de) |
EP (2) | EP2272947B1 (de) |
AT (1) | ATE466069T1 (de) |
AU (1) | AU2001288025A1 (de) |
DE (1) | DE60141992D1 (de) |
IL (1) | IL154696A (de) |
WO (1) | WO2002020715A2 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201863D0 (en) * | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
US7230101B1 (en) | 2002-08-28 | 2007-06-12 | Gpc Biotech, Inc. | Synthesis of methotrexate-containing heterodimeric molecules |
MXPA05011233A (es) * | 2003-04-22 | 2005-12-14 | Conseils De Rech S Et D Aplica | Vectores peptidicos. |
EP1635858A4 (de) * | 2003-05-29 | 2009-08-26 | Scripps Research Inst | Gezielte abgabe an legumain exprimierende zellen |
AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
WO2005097089A2 (en) * | 2004-04-02 | 2005-10-20 | Wisconsin Alumni Research Foundation | Derivatives of leinamycin for use as anticancer agents |
EA016186B1 (ru) * | 2005-09-26 | 2012-03-30 | Медарекс, Инк. | Человеческие моноклональные антитела к cd70 и их применение |
CN101374856A (zh) * | 2005-11-29 | 2009-02-25 | 斯克里普斯研究学院 | 抑制肿瘤细胞浸润、转移和血管生成 |
MX2009006277A (es) * | 2006-12-14 | 2009-07-24 | Medarex Inc | Anticuerpos humanos que se enlazan a cd70 y usos de los mismos. |
WO2008139457A2 (en) * | 2007-05-10 | 2008-11-20 | Clear Direction Ltd. | Methods and compositions for drug targeting |
KR101032860B1 (ko) * | 2008-10-22 | 2011-05-06 | 한국식품연구원 | 췌장 조직 특이적 유전자 mmp1 |
CN101747411B (zh) * | 2008-11-28 | 2012-07-25 | 北京大学 | 氨基酰色氨酰色氨酸三肽苄酯及其制备方法和应用 |
EP2488874A4 (de) * | 2009-10-13 | 2013-08-14 | Univ Johns Hopkins | Biomarker zur identifikation von melanomtumorzellen |
AR077384A1 (es) | 2010-07-05 | 2011-08-24 | Eriochem Sa | Una formulacion farmaceutica inyectable de melfalano. |
SG189370A1 (en) * | 2010-12-03 | 2013-05-31 | Adamed Sp Zoo | Anticancer fusion protein |
PL394618A1 (pl) * | 2011-04-19 | 2012-10-22 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9155799B2 (en) | 2012-11-19 | 2015-10-13 | Mimedx Group, Inc. | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent |
US8946163B2 (en) * | 2012-11-19 | 2015-02-03 | Mimedx Group, Inc. | Cross-linked collagen comprising metallic anticancer agents |
US8940684B2 (en) | 2012-11-19 | 2015-01-27 | Mimedx Group, Inc. | Cross-linked collagen comprising an antifungal agent |
US10029030B2 (en) | 2013-03-15 | 2018-07-24 | Mimedx Group, Inc. | Molded placental tissue compositions and methods of making and using the same |
US10335433B2 (en) | 2013-04-10 | 2019-07-02 | Mimedx Group, Inc. | NDGA polymers and metal complexes thereof |
US9446142B2 (en) | 2013-05-28 | 2016-09-20 | Mimedx Group, Inc. | Polymer chelator conjugates |
US10449220B2 (en) | 2013-08-30 | 2019-10-22 | Mimedx Group, Inc. | Micronized placental compositions comprising a chelator |
KR102272213B1 (ko) * | 2014-07-08 | 2021-07-01 | 삼성전자주식회사 | 표적화 부위, 절단 부위, 및 세포막 투과 부위를 포함하는 융합 단백질 및 그의 용도 |
BR112018011178A2 (pt) | 2015-12-03 | 2018-11-21 | Biosight Ltd | sais de conjugados para terapia de câncer |
US11939609B2 (en) | 2017-07-24 | 2024-03-26 | The Board Of Trustees Of The Leland Stanford Junior University | Rewiring aberrant cancer signaling to a therapeutic effector response with a synthetic two-component system |
WO2019136185A1 (en) * | 2018-01-08 | 2019-07-11 | Susavion Biosciences, Inc. | Compositions and methods of treating cancer with glycomimetic peptides |
KR102544277B1 (ko) * | 2020-01-15 | 2023-06-16 | 재단법인대구경북과학기술원 | 세포외 기질 및 항암제로 이루어진 접합체 및 이의 의학적 용도 |
US20210402001A1 (en) * | 2020-06-30 | 2021-12-30 | David I. Cohen | Zinc Porters, and their Monoclonal Antibody Conjugates, for the Prevention and Treatment of COVID-19 (SARS-CoV-2), Other Infections, and Cancers |
TW202328170A (zh) * | 2021-09-14 | 2023-07-16 | 美商艾希利歐發展股份有限公司 | 可裂解連接子 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983000150A1 (en) * | 1981-07-02 | 1983-01-20 | Walton, Alan, G. | Glycosaminoglycan drug complexes |
GB8907617D0 (en) * | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
DE69418322D1 (de) * | 1993-03-01 | 1999-06-10 | Glycan Pharm Inc | Analoge für spezifische oligosaccharid-protein-wechselwirkungen und ihre verwendungen |
EP0694042B1 (de) | 1993-03-25 | 2004-11-03 | Merck & Co. Inc. | Inhibitor des wachstumsfaktors für gefäss-endothelzellen |
US5612474A (en) * | 1994-06-30 | 1997-03-18 | Eli Lilly And Company | Acid labile immunoconjugate intermediates |
US5871723A (en) | 1995-06-06 | 1999-02-16 | The Regent Of The University Of Michigan | CXC chemokines as regulators of angiogenesis |
DE19701141C1 (de) * | 1997-01-16 | 1998-04-09 | Hoechst Ag | Genkonstrukte für durch Proteasen aktivierbare Wirksubstanzen |
BR0010017A (pt) * | 1999-04-28 | 2002-06-11 | Univ Texas | Composições e processos para o tratamento de câncer por inibição seletiva de vegf |
CN101374856A (zh) * | 2005-11-29 | 2009-02-25 | 斯克里普斯研究学院 | 抑制肿瘤细胞浸润、转移和血管生成 |
-
2001
- 2001-09-05 AT AT01967657T patent/ATE466069T1/de not_active IP Right Cessation
- 2001-09-05 EP EP10156533.1A patent/EP2272947B1/de not_active Expired - Lifetime
- 2001-09-05 DE DE60141992T patent/DE60141992D1/de not_active Expired - Lifetime
- 2001-09-05 AU AU2001288025A patent/AU2001288025A1/en not_active Abandoned
- 2001-09-05 EP EP01967657A patent/EP1581615B1/de not_active Expired - Lifetime
- 2001-09-05 IL IL154696A patent/IL154696A/en active IP Right Grant
- 2001-09-05 WO PCT/IL2001/000839 patent/WO2002020715A2/en active Application Filing
-
2003
- 2003-03-05 US US10/382,240 patent/US7135547B2/en not_active Expired - Lifetime
-
2006
- 2006-11-02 US US11/555,939 patent/US7638127B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20030216298A1 (en) | 2003-11-20 |
EP2272947A1 (de) | 2011-01-12 |
WO2002020715A2 (en) | 2002-03-14 |
ATE466069T1 (de) | 2010-05-15 |
EP1581615A2 (de) | 2005-10-05 |
IL154696A (en) | 2008-11-03 |
US7135547B2 (en) | 2006-11-14 |
AU2001288025A8 (en) | 2006-11-02 |
IL154696A0 (en) | 2003-09-17 |
AU2001288025A1 (en) | 2002-03-22 |
WO2002020715A3 (en) | 2006-01-12 |
US20070160573A1 (en) | 2007-07-12 |
EP1581615A4 (de) | 2005-10-05 |
EP1581615B1 (de) | 2010-04-28 |
EP2272947B1 (de) | 2016-08-10 |
US7638127B2 (en) | 2009-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60141992D1 (de) | ||
WO2000061788A3 (en) | Poly(dipeptide) as a drug carrier | |
WO2002000263A3 (en) | Tripeptide prodrug compounds | |
GEP20043200B (en) | Therapeutic Agent Comprising a Botulinum Neurotoxin | |
NO20015584L (no) | Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling | |
PT1162995E (pt) | Enzimas para o tratamento da diabetes mellitus do tipo i | |
WO2003079972A3 (en) | Active agent delivery systems and methods for protecting and administering active agents | |
WO1995030410A3 (en) | Transdermal device for administration through de-epithelialized skin | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
WO2002013873A3 (en) | P97-active agent conjugates and their methods of use | |
HUP0100669A3 (en) | Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof | |
RU2010127336A (ru) | Фармацевтический препарат для лечения доброкачественной гиперплазии предстательной железы | |
GR3035593T3 (en) | Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases | |
AU2001264515A1 (en) | Melphalan derivatives and their use as cancer chemotherapeutic drugs | |
AU2002236100A1 (en) | New therapeutic uses of smr1 peptides | |
WO2001085777A3 (en) | Therapeutic pore-forming peptides | |
WO2002053090A3 (fr) | Association medicamenteuse d'une biguanine (metformine) et d'arginine | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
GB2411404A (en) | Biologically active peptide conjugates | |
UA27132C2 (uk) | Двофуhкціоhальhі варіаhти урокіhази зі зміцнеhою фібриhолітичhою властивістю і тромбіh-іhгібуючою дією | |
AU3739500A (en) | Protease resistant flint analogs | |
WO2006135930A3 (en) | Transmucosal delivery of peptide derivatives | |
CA2373252A1 (en) | Long lasting anti-angiogenic peptides | |
WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
WO2001022917A3 (en) | Effervescent compositions comprising nimesulide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |